Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik A Barth

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
Clinical Genitourinary Cancer|April 21, 2022
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score AnalysisFranziska Maisel, Maria A Smolle, Stefanie Mollnar, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort studyDominik A Barth, Florian Moik, Sarah Steinlechner, et al.
Pageof 3